Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Cardiff Oncology, Inc. | d584926ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Trovagene, Inc.
San Diego, California
We hereby consent to the use in this Prospectus constituting a part of this Registration Statement of our report dated February 26, 2018, relating to the consolidated financial statements of Trovagene, Inc. (the “Company”), which is contained by reference in that Prospectus. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
San Diego, California
May 9, 2018